Posted by Jeff Daas on Mar 9th, 2010 | No Comments
Postmenopausal women, including those over 70 years old, who have been newly diagnosed with cancer in one breast have higher cancer detection rates when the other breast is scanned for tumors with MRI, compared to premenopausal women, say researchers at the Mayo Clinic campus in Florida. They found that 3…
Read Full Article
Posted by Jeff Daas on Mar 9th, 2010 | No Comments
One in three early stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of the disease recurring, a new study has found…
Read Full Article
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies…
Read Full Article
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies…
Read Full Article
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
Life Technologies Corporation (NASDAQ:LIFE) announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies…
Read Full Article
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence. About one in four experienced distress when receiving their test results…
Read Full Article
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
Breast cancer patients with early stage disease that has spread to only one lymph node may not benefit from radiation after mastectomy, because of the low present-day risk of recurrence following modern surgery and systemic therapy, a finding that could one day change the course of treatment for thousands of women diagnosed each year, according to researchers at The University of Texas M. D…
Read...
Posted by Jeff Daas on Mar 8th, 2010 | No Comments
Life Technologies Corporation (NASDAQ: LIFE) has announced that it is collaborating with the Translational Genomics Research Institute (TGen) and US Oncology to sequence the genomes of 14 patients afflicted with triple negative breast cancer whose tumors have progressed despite multiple other therapies…
Read Full Article
Posted by Jeff Daas on Mar 7th, 2010 | No Comments
Amber J. Belcher, a doctoral student in psychology at the University of Delaware, has won the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (NIH). The fellowship will support Belcher’s research on how couples cope with breast cancer. Breast cancer is second only to skin cancer as the most common cancer among women in the United States…
Read...
Posted by Jeff Daas on Mar 5th, 2010 | No Comments
A new study, led by researchers at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. Results were published in the Journal of Clinical Oncology…
Read Full...